Angiolutions strengthens intellectual property protection
Angiolutions strengthens intellectual property protection for its early aortic aneurysm treatment: second US patent granted Second US patent granted in
News & Updates
Angiolutions strengthens intellectual property protection for its early aortic aneurysm treatment: second US patent granted
Second US patent granted in May, first EU patent granted in July; Increasing total patent portfolio to 16 patents and applications; Intellectual property (IP) portfolio protects innovation from multiple angles.
Angiolutions announces advisory board to accelerate early-stage treatment for abdominal aortic aneurysms
July 3, 2024 – Angiolutions announces its Advisory Board, comprising industry leaders, distinguished researchers, and clinicians from world-renowned institutions. Each member brings unique expertise to advance Angiolutions' mission of delivering the first implant designed to prevent abdominal aortic aneurysms at an early stage to patients.
Angiolutions wins START HEALTHCARE competition
June 18, 2024 – Angiolutions won first place in the competition START HEALTHCARE which was held at the MedtecLIVE Tradefair in Stuttgart.
Angiolutions secures €2.5 million European Innovation Council grant to fast-track its groundbreaking aneurysm treatment
July 27th, 2023, Angiolutions has been awarded the prestigious European Innovation Council (EIC) Accelerator Grant and will receive €2.5 million in funding for its groundbreaking treatment for early-stage abdominal aortic aneurysms.
Angiolutions receives ISO 13485 certification
for its fully digital quality management system
As of December 22, 2021, Angiolutions is ISO 13485 certified. This ensures highest levels of quality and patient safety in our journey to bring the first device to treat small abdominal aortic aneurysms (AAAs) to market and to help hundred thousands of patients.
Stay in touch
receive update emails a few times a year
Angiolutions in the media
Die tickende Zeitbombe
04.03.2021 | nbank.de
"Angiolutions entwickelt ein neuartiges Gefäßimplantat, das zum ersten Mal eine spezifische minimalinvasive Behandlung kleiner Bauchaortenaneurysmen ermöglicht [...]"
read more
Im Austausch mit der Gesellschaft
16.02.2021 | deutschland.de
"Medizinische Forschung: Isabel Schellinger arbeitet als Ärztin und ist Gründerin eines wissenschaftsbasierten Startups[...]"
read more
Media Kit
further content about Angiolutions
Document title
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Document title
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
